Skip to content

Effect of vasopressin and norepinephrine on Renal function of patients undergoing CABG in Emam Khomeini hospital of Ardabil

Effect of vasopressin and norepinephrine on Renal function of patients undergoing CABG in Emam Khomeini hospital of Ardabil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201412054256N4
Enrollment
120
Registered
2015-02-14
Start date
2015-01-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open heart sergury. Ischaemic heart diseases

Interventions

Intervention 1: Vassopressin 0.01-0.04 u/min in artery pressure below 50 mm/Hg. Intervention 2: control: Norepinephrine 1-4 u/min in artery pressure below 50 mm Hg.
Treatment - Drugs
Vassopressin 0.01-0.04 u/min in artery pressure below 50 mm/Hg
control: Norepinephrine 1-4 u/min in artery pressure below 50 mm Hg

Sponsors

Ardabil University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 30 years old and more; IHD had been diagnosed by angiography, and absence of mental problems. Exclusion criteria: patients who, had had chronic renal failure and creatinin more than 1.5 were excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood urine nitrogen. Timepoint: Before intervention, after intervention. Method of measurement: Biochemical blood test, urine volume in 24 hours.;Creatinin. Timepoint: Before intervention, after intervention. Method of measurement: Biochemical blood test, urine volume in 24 hours.

Secondary

MeasureTime frame
In crease creatinin, decease clearance creatinin. Timepoint: Before,24 hours after intervention. Method of measurement: Biochemical blood test, urine volume in 24 hours.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJafar Vakili

Ardabil university of medical sciences

Vakili_jafar@yahoo.com, na.samadi@arums.ac.ir+98 45 3325 1401

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026